DexCom, Inc.DXCMNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P33
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -5.48% |
| Q3 2025 | 58.70% |
| Q2 2025 | 70.37% |
| Q1 2025 | -30.77% |
| Q4 2024 | 11.43% |
| Q3 2024 | -2.78% |
| Q2 2024 | -5.26% |
| Q1 2024 | -43.28% |
| Q4 2023 | 116.13% |
| Q3 2023 | 3.33% |
| Q2 2023 | 130.77% |
| Q1 2023 | -45.83% |
| Q4 2022 | 0.00% |
| Q3 2022 | 84.62% |
| Q2 2022 | -43.48% |
| Q1 2022 | 560.00% |
| Q4 2021 | -121.74% |
| Q3 2021 | 15.00% |
| Q2 2021 | 33.33% |
| Q1 2021 | -34.78% |
| Q4 2020 | 21.05% |
| Q3 2020 | 58.33% |
| Q2 2020 | 118.18% |
| Q1 2020 | -78.00% |
| Q4 2019 | 92.31% |
| Q3 2019 | 533.33% |
| Q2 2019 | 60.00% |
| Q1 2019 | 85.29% |
| Q4 2018 | -492.31% |
| Q3 2018 | 52.94% |
| Q2 2018 | 222.66% |
| Q1 2018 | -149.28% |
| Q4 2017 | -379.31% |
| Q3 2017 | -177.33% |
| Q2 2017 | 106.25% |
| Q1 2017 | -447.95% |
| Q4 2016 | 60.82% |
| Q3 2016 | 7.45% |
| Q2 2016 | -3.25% |
| Q1 2016 | -1270.00% |